VERA - Vera Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

235.4M

Cash

197.2M

Avg Qtr Burn

-21.23M

Short % of Float

9.00%

Insider Ownership

5.72%

Institutional Own.

69.67%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Atacicept Details Lupus nephritis	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Atacicept (Origin) Details IgA nephropathy	Phase 2b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MAU868 Details Kidney transplantation, BK virus	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.